Clinical Trial Update: Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports completion of a study evaluating ferric carboxymaltose for improving fatigue in iron-deficient non-anemic women of childbearin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency

Drugs mentioned

• Ferinject (ferric carboxymaltose)

Snippet

Sponsor: Vifor Pharma | Conditions: Iron Deficiency | Phase 4 | Status: COMPLETED